Moderna (MRNA) Current Assets (2017 - 2026)
Moderna's Current Assets came in at $5.82 billion for Q2 2026, down 5.8% from $6.17 billion a year earlier but up 0.8% from the prior quarter.
Analysis
Moderna (MRNA) Current Assets (2017 - 2026) Analysis & Trends
At the end of FY2025, Moderna's Current Assets was $6.54 billion, down 19.2% from FY2024.
- Current Assets has declined in each of the last four years, though with a five-year compound annual growth rate of 0.8% (FY2020 to FY2025).
- Going back by year, Current Assets was $8.1 billion in FY2024 (-21.6%), $10.33 billion in FY2023 (-23.1%), $13.43 billion in FY2022 (-16.4%) and $16.07 billion in FY2021 (+155.2%).
- The five-year range for quarterly Current Assets is $5.77 billion (Q1 2026) to $16.35 billion (Q1 2022).
- Year-over-year, Current Assets has declined for 15 consecutive quarters, with an average decline of 21.1% over the last eight quarters.
- The fastest year-over-year change in Current Assets over five years came in Q3 2021 (growth of 275.3%), and the weakest in Q2 2025 (a decline of 36.1%).
- Business Quant data shows MRNA's Current Assets at $5.77 billion (Q1 2026), $6.54 billion (Q4 2025) and $6.6 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 59.77 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 41.36 Bn |
| 10 | Moderna | 85.93 Bn | 65.29 Bn | 52.00 Mn | 5.82 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.82 Bn |
| Mar 31, 2026 | 5.77 Bn |
| Dec 31, 2025 | 6.54 Bn |
| Sep 30, 2025 | 6.60 Bn |
| Jun 30, 2025 | 6.17 Bn |
| Mar 31, 2025 | 6.77 Bn |
| Dec 31, 2024 | 8.10 Bn |
| Sep 30, 2024 | 9.67 Bn |
| Jun 30, 2024 | 9.66 Bn |
| Mar 31, 2024 | 9.60 Bn |
| Dec 31, 2023 | 10.33 Bn |
| Sep 30, 2023 | 10.80 Bn |
| Jun 30, 2023 | 10.60 Bn |
| Mar 31, 2023 | 12.12 Bn |
| Dec 31, 2022 | 13.43 Bn |
| Sep 30, 2022 | 14.30 Bn |
| Jun 30, 2022 | 13.56 Bn |
| Mar 31, 2022 | 16.35 Bn |
| Dec 31, 2021 | 16.07 Bn |
| Sep 30, 2021 | 13.43 Bn |
API Access
Moderna Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=MRNA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "MRNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=MRNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();